Nemocnice Hořovice
- Address
- K Nemocnice 1106, 268 31 Horovice, Czechia
Nemocnice Hořovice - Gastroenterology Clinical Research
Nemocnice Hořovice is a clinical research facility actively engaged in advancing therapeutic options for patients with inflammatory bowel diseases. The center specializes in evaluating novel biologic therapies and contributes to international multicenter trials focused on chronic gastrointestinal conditions.
- Innovative treatments for moderate to severe Crohn's disease
- Safety and tolerability assessments of subcutaneous biologic agents
- Phase 2 clinical trials in inflammatory bowel disease management
The research team at Nemocnice Hořovice demonstrates particular expertise in Crohn's disease clinical studies, evaluating cutting-edge therapeutic agents designed to improve outcomes for patients with active inflammatory bowel disease. Their participation in double-blind controlled trials contributes valuable data to the global understanding of emerging biologic treatments and their role in managing complex gastrointestinal disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Nemocnice Hořovice
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 2 Multicenter Double-Blind Study of Subcutaneous PF-06480605 in Moderate to Severe Active Crohn's Disease | F. Hoffmann-La Roche AG | Phase II | Not Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pf-06480605 | 1 | Unknown | 2023-10-23 | 2023-10-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.